Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia 4Myelodysplastic Syndromes 2Multiple Myeloma 2Leukemia, Myeloid, Acute 2Recurrence 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms, Plasma Cell 1Lymphoma 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Myeloid 1Hodgkin Disease 1Hematologic Neoplasms 1Congenital Abnormalities 1Blast Crisis 1

Interventions

Methotrexate 9Cyclophosphamide 9fludarabine phosphate 7Vincristine 7Rituximab 7Tacrolimus 6Cytarabine 6nelarabine 5Whole-Body Irradiation 5Peripheral Blood Stem Cell Transplantation 5Mycophenolic Acid 5Filgrastim 5Dexamethasone 5Antilymphocyte Serum 5pegaspargase 4merphos 4Prednisone 4Granulocyte Colony-Stimulating Factor 4Etoposide 4Calcium Dobesilate 4tanespimycin 3dexamethasone acetate 3dexamethasone 21-phosphate 3Radiotherapy 3Lenalidomide 3Doxorubicin 3Busulfan 3Bortezomib 3prednylidene 2deltacortene 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × Methylprednisolone Acetate × Clear all
NCT01005914 2023-01-06

Pegaspargase and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

OHSU Knight Cancer Institute

Phase 2 Terminated
11 enrolled 6 charts
LymphoidOther hematologic neoplasm

Leukemia, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡